| |
| |
|
| Insider
Information: |
Garg Pushkal |
| Relationship: |
CMO & EVP Dev & Med Af... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,417 |
|
|
Indirect Shares
|
681 |
|
|
| Direct
Value |
$1,931,377 |
|
|
|
Indirect Value
|
$98,030 |
|
|
| Total
Shares |
14,098 |
|
|
| Total
Value |
$2,029,407 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
CMO & EVP Dev & Med Af... |
2024-03-01 |
13,417 |
2024-03-01 |
681 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,751 |
13,417 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2024-02-28 |
4 |
S |
$154.54 |
$89,145 |
D/D |
(574) |
8,666 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2024-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,908 |
9,240 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2024-02-16 |
4 |
S |
$147.50 |
$193,666 |
D/D |
(1,308) |
7,332 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,295 |
8,640 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-08-07 |
4 |
AS |
$183.58 |
$766,083 |
D/D |
(4,166) |
4,345 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-08-04 |
4 |
AS |
$184.70 |
$643,223 |
D/D |
(3,461) |
8,511 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,627 |
11,972 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-04-28 |
4 |
AS |
$195.46 |
$488,595 |
D/D |
(2,455) |
4,345 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-04-27 |
4 |
AS |
$193.18 |
$357,855 |
D/D |
(1,839) |
6,800 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,294 |
8,639 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-03-03 |
4 |
AS |
$200.00 |
$3,614,400 |
D/D |
(18,072) |
4,345 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2023-03-03 |
4 |
OE |
$96.45 |
$482,250 |
D/D |
5,000 |
22,417 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2022-08-04 |
4 |
D |
$189.76 |
$974,201 |
D/D |
(5,086) |
17,417 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med Affairs |
• – – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,311 |
22,503 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med AffairsOff |
• – – |
2021-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
681 |
|
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CMO & EVP Dev & Med AffairsOff |
• – – |
2021-12-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,192 |
|
% |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
